Healthcare / Medical Care FacilitiesXETRA
$12.40
-0.20 (-1.60%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $46.2M · quality 66.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
50/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$830M
P/E
21.8x
↑EV/EBITDA
5.7x
↓ROE
3.3%
↑Gross Margin
10.8%
↓Debt/Equity
0.12
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+4.4%
FCF CAGR
+42.7%
FCF margin
3.6%
FCF / Net income
1.32x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.60B · net income $43.4M · FCF $57.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.60B | $1.60B | $1.46B | $1.45B | $1.40B |
| Net Income | $43.4M | $43.4M | $38.7M | $25.1M | $28.3M |
| EBITDA | $122.2M | $122.2M | $117.0M | $107.3M | $101.2M |
| EPS | 0.65 | 0.65 | 0.58 | 0.38 | 0.42 |
| Gross Margin | 10.8% | 10.8% | 10.2% | 13.8% | 14.1% |
| Operating Margin | 2.4% | 2.4% | 2.0% | 2.5% | 2.1% |
| Net Margin | 2.7% | 2.7% | 2.6% | 1.7% | 2.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.12 | 0.12 | 0.12 | 0.13 | 0.13 |
| Current Ratio | 2.57 | 2.57 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $57.2M | $57.2M | $46.2M | $2.1M | $19.7M |
| Returns | |||||
| ROE | 3.3% | 3.3% | 3.1% | 2.1% | 2.4% |
| Valuation | |||||
| P/E | 21.75 | 21.75 | 17.41 | 39.47 | 34.95 |
| EV/EBITDA | 5.73 | 5.73 | 5.30 | 10.11 | 10.04 |
| P/B | 0.64 | 0.64 | 0.54 | 0.82 | 0.82 |
| Growth & Yield | |||||
| Revenue Growth | 9.0% | 9.0% | 1.2% | 3.1% | — |
| EPS Growth | 12.1% | 12.1% | 52.6% | -9.5% | — |
| Dividend Yield | 1.6% | 1.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
19.2%
EPS terminal req.
$1.10
Spread vs growth
-7.1%
5Y implied EPS CAGR
15.4%
EPS terminal req.
$1.33
Spread vs growth
-3.3%
10Y implied EPS CAGR
12.7%
EPS terminal req.
$2.14
Spread vs growth
-0.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-1.5%
Start / end P/E
21.9x → 18.9x
EPS bridge
0.58 → 0.65
Residual
-1.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.